New hepatitis C wonder drug shakes up the health care industry with remarkable success and $1,000/pill price

In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen. The cost: $168,000, or an eye-popping $1,000 per pill. The company says Sovaldiís price reflects its 90 percent-plus cure rate for hepatitis C and the savings that produces by cutting patientsí long-term treatment costs, which can include hospitalizations, surgeries and even liver transplants.
CLICK TO VIEW THE SOURCE MATERIAL